Cargando…

Probiotics and Atopic Dermatitis: An Overview

Atopic dermatitis (AD) is a common, recurrent, chronic inflammatory skin disease that is a cause of considerable economic and social burden. Its prevalence varies substantially among different countries with an incidence rate proclaimed to reach up to 20% of children in developed countries and conti...

Descripción completa

Detalles Bibliográficos
Autores principales: Rather, Irfan A., Bajpai, Vivek K., Kumar, Sanjay, Lim, Jeongheui, Paek, Woon K., Park, Yong-Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828648/
https://www.ncbi.nlm.nih.gov/pubmed/27148196
http://dx.doi.org/10.3389/fmicb.2016.00507
_version_ 1782426626007498752
author Rather, Irfan A.
Bajpai, Vivek K.
Kumar, Sanjay
Lim, Jeongheui
Paek, Woon K.
Park, Yong-Ha
author_facet Rather, Irfan A.
Bajpai, Vivek K.
Kumar, Sanjay
Lim, Jeongheui
Paek, Woon K.
Park, Yong-Ha
author_sort Rather, Irfan A.
collection PubMed
description Atopic dermatitis (AD) is a common, recurrent, chronic inflammatory skin disease that is a cause of considerable economic and social burden. Its prevalence varies substantially among different countries with an incidence rate proclaimed to reach up to 20% of children in developed countries and continues to escalate in developing nations. This increased rate of incidence has changed the focus of research on AD toward epidemiology, prevention, and treatment. The effects of probiotics in the prevention and treatment of AD remain elusive. However, evidence from different research groups show that probiotics could have positive effect on AD treatment, if any, that depend on multiple factors, such as specific probiotic strains, time of administration (onset time), duration of exposure, and dosage. However, till date we still lack strong evidence to advocate the use of probiotics in the treatment of AD, and questions remain to be answered considering its clinical use in future. Based on updated information, the processes that facilitate the development of AD and the topic of the administration of probiotics are addressed in this review.
format Online
Article
Text
id pubmed-4828648
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-48286482016-05-04 Probiotics and Atopic Dermatitis: An Overview Rather, Irfan A. Bajpai, Vivek K. Kumar, Sanjay Lim, Jeongheui Paek, Woon K. Park, Yong-Ha Front Microbiol Microbiology Atopic dermatitis (AD) is a common, recurrent, chronic inflammatory skin disease that is a cause of considerable economic and social burden. Its prevalence varies substantially among different countries with an incidence rate proclaimed to reach up to 20% of children in developed countries and continues to escalate in developing nations. This increased rate of incidence has changed the focus of research on AD toward epidemiology, prevention, and treatment. The effects of probiotics in the prevention and treatment of AD remain elusive. However, evidence from different research groups show that probiotics could have positive effect on AD treatment, if any, that depend on multiple factors, such as specific probiotic strains, time of administration (onset time), duration of exposure, and dosage. However, till date we still lack strong evidence to advocate the use of probiotics in the treatment of AD, and questions remain to be answered considering its clinical use in future. Based on updated information, the processes that facilitate the development of AD and the topic of the administration of probiotics are addressed in this review. Frontiers Media S.A. 2016-04-12 /pmc/articles/PMC4828648/ /pubmed/27148196 http://dx.doi.org/10.3389/fmicb.2016.00507 Text en Copyright © 2016 Rather, Bajpai, Kumar, Lim, Paek and Park. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Rather, Irfan A.
Bajpai, Vivek K.
Kumar, Sanjay
Lim, Jeongheui
Paek, Woon K.
Park, Yong-Ha
Probiotics and Atopic Dermatitis: An Overview
title Probiotics and Atopic Dermatitis: An Overview
title_full Probiotics and Atopic Dermatitis: An Overview
title_fullStr Probiotics and Atopic Dermatitis: An Overview
title_full_unstemmed Probiotics and Atopic Dermatitis: An Overview
title_short Probiotics and Atopic Dermatitis: An Overview
title_sort probiotics and atopic dermatitis: an overview
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828648/
https://www.ncbi.nlm.nih.gov/pubmed/27148196
http://dx.doi.org/10.3389/fmicb.2016.00507
work_keys_str_mv AT ratherirfana probioticsandatopicdermatitisanoverview
AT bajpaivivekk probioticsandatopicdermatitisanoverview
AT kumarsanjay probioticsandatopicdermatitisanoverview
AT limjeongheui probioticsandatopicdermatitisanoverview
AT paekwoonk probioticsandatopicdermatitisanoverview
AT parkyongha probioticsandatopicdermatitisanoverview